These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29932454)

  • 21. Prescription use of paracetamol and risk for ovarian cancer in Denmark.
    Baandrup L; Friis S; Dehlendorff C; Andersen KK; Olsen JH; Kjaer SK
    J Natl Cancer Inst; 2014 Jun; 106(6):dju111. PubMed ID: 24848623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
    Arslan AA; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Lukanova A; Afanasyeva Y; Lenner P; Krogh V; Muti P; Rinaldi S; Kaaks R; Berrino F; Hallmans G; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1531-5. PubMed ID: 14693749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health Care Utilization Prior to Ovarian Cancer Diagnosis in Publicly Insured Individuals in New York State.
    Gates Kuliszewski M; Boscoe FP; Wagner VL; Schymura MJ
    J Registry Manag; 2021; 48(3):126-137. PubMed ID: 35413730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland.
    Koskela-Niska V; Pukkala E; Lyytinen H; Ylikorkala O; Dyba T
    Int J Cancer; 2013 Oct; 133(7):1680-8. PubMed ID: 23526244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving Concepts in the Management of Newly Diagnosed Epithelial Ovarian Cancer.
    Gourley C; Bookman MA
    J Clin Oncol; 2019 Sep; 37(27):2386-2397. PubMed ID: 31403859
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of epithelial ovarian cancer.
    Leitao MM
    Clin Adv Hematol Oncol; 2018 Oct; 16(10):656-659. PubMed ID: 30543594
    [No Abstract]   [Full Text] [Related]  

  • 27. Hormone therapy and different ovarian cancers: a national cohort study.
    Mørch LS; Løkkegaard E; Andreasen AH; Kjaer SK; Lidegaard O
    Am J Epidemiol; 2012 Jun; 175(12):1234-42. PubMed ID: 22517811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management and Treatment of Recurrent Epithelial Ovarian Cancer.
    Armbruster S; Coleman RL; Rauh-Hain JA
    Hematol Oncol Clin North Am; 2018 Dec; 32(6):965-982. PubMed ID: 30390768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
    Bandera EV; Lee VS; Rodriguez-Rodriguez L; Powell CB; Kushi LH
    JAMA Oncol; 2015 Sep; 1(6):737-45. PubMed ID: 26181758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.
    Barclay M; Gildea C; Poole J; Hirschowitz L; Menon U; Nordin A
    Int J Gynecol Cancer; 2016 Jan; 26(1):56-65. PubMed ID: 26509852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study.
    Jordan S; Steer C; DeFazio A; Quinn M; Obermair A; Friedlander M; Francis J; O'Brien S; Goss G; Wyld D; Australian Ovarian Cancer Study Group ; Webb P;
    Gynecol Oncol; 2013 May; 129(2):310-7. PubMed ID: 23403164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.
    Gaist D
    Cephalalgia; 1999 Oct; 19(8):735-61. PubMed ID: 10570730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated Urethral Metastasis From a Primary Ovarian Malignancy.
    Allan M; Tailor A; Butler-Manuel S; Madhuri TK
    J Obstet Gynaecol Can; 2018 Dec; 40(12):1632-1634. PubMed ID: 30262385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.
    Trétarre B; Molinié F; Woronoff AS; Bossard N; Bessaoud F; Marrer E; Grosclaude P; Guizard AV; Delafosse P; Bara S; Velten M; Lapôtre-Ledoux B; Ligier K; Léone N; Arveux P; Uhry Z
    Gynecol Oncol; 2015 Nov; 139(2):324-9. PubMed ID: 26383829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic.
    Wahner Hendrickson AE; Hawthorne KM; Goode EL; Kalli KR; Goergen KM; Bakkum-Gamez JN; Cliby WA; Keeney GL; Visscher DW; Tarabishy Y; Oberg AL; Hartmann LC; Maurer MJ
    Gynecol Oncol; 2015 Apr; 137(1):77-85. PubMed ID: 25620544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
    Vogel TJ; Goodman MT; Li AJ; Jeon CY
    Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States.
    Cramer DW; Vitonis AF; Terry KL; Welch WR; Titus LJ
    Epidemiology; 2016 May; 27(3):334-46. PubMed ID: 26689397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian cancer outcomes: Predictors of early death.
    Urban RR; He H; Alfonso R; Hardesty MM; Gray HJ; Goff BA
    Gynecol Oncol; 2016 Mar; 140(3):474-80. PubMed ID: 26743531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The World Ovarian Cancer Coalition Every Woman Study: identifying challenges and opportunities to improve survival and quality of life.
    Reid F; Bhatla N; Oza AM; Blank SV; Cohen R; Adams T; Benites A; Gardiner D; Gregory S; Suzuki M; Jones A
    Int J Gynecol Cancer; 2021 Feb; 31(2):238-244. PubMed ID: 32540894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.